Yasuo Hirono

Prof. Dr. Yasuo Hirono

orcid
Director of Cancer Care Promotion Center, University of Fuku...

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2007
Verified
Journal Article
Closed access
KKKenji Koneri
Kenji Koneri
TGTakanori Goi
Takanori Goi
YHYasuo Hirono
Yasuo Hirono
KKKanji Katayama
Kanji Katayama
AYAkio Yamaguchi
Akio Yamaguchi

19 August 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
DFDaisuke Fujimoto
Daisuke Fujimoto
YHYasuo Hirono
Yasuo Hirono
TGTakanori Goi
Takanori Goi
KKKanji Katayama
Kanji Katayama
SMShigeru Matsukawa
Shigeru Matsukawa
AYAkio Yamaguchi
Akio Yamaguchi
In addition to regulating platelet function, the G protein-coupled sub-family member Proteinase-activated receptor-1 (PAR1) has a proposed role in the development of various cancers, but its exact role and mechanism of action in the invasion, metastasis, and proliferation process in gastric cancer have yet to be completely elucidated. Here, we analyzed the relationship between PAR1 activation, proliferation, invasion, and the signaling pathways downstream of PAR1 activation in gastric cancer.


14 December 2012 in International Journal of Oncology
Verified
Journal Article
Closed access
DFDaisuke Fujimoto
Daisuke Fujimoto
YHYasuo Hirono
Yasuo Hirono
TGTakanori Goi
Takanori Goi
KKKanji Katayama
Kanji Katayama
SMShigeru Matsukawa
Shigeru Matsukawa
AYAkio Yamaguchi
Akio Yamaguchi
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

26 November 2016 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MMMakoto Murakami
Makoto Murakami
KKKanji Katayama
Kanji Katayama
SKShigeru Kato
Shigeru Kato
DFDaisuke Fujimoto
Daisuke Fujimoto
MMMitsuhiro Morikawa
Mitsuhiro Morikawa
TGTakanori Goi
Takanori Goi
Large-cell neuroendocrine carcinoma (LCNEC) of the bile duct is extremely rare and is a high-grade type of neuroendocrine tumor with an aggressive clinical course. Here, we report a case of LCNEC of the extrahepatic bile duct. An 80-year-old man presented with severe jaundice. Endoscopic retrograde cholangiography and enhanced computed tomography revealed complete obstruction of the common bile duct (CBD) by a dense tumor measuring 1.5 cm in diameter. Although there were no malignant cells in the biliary brush cytology, we suspected a cholangiocarcinoma and performed extrahepatic bile duct resection. Histologically, the LCNEC occupied most of the places deeper than the stratum submucosum and an adenocarcinoma component, approximately 15%, was present in the mucosa. There were no transitional areas between the two components. Immunohistochemically, the LCNEC cells were reactive for CD56 and synaptophysin and had a high MIB-1 index (72%). The patient died of multiple liver, lung, and peritoneal metastases 3 months after surgery. LCNEC of the CBD is particularly rare and has a very poor prognosis. Only five cases have been reported in the literature; therefore, there is no established effective therapy, including surgery, for LCNEC of the CBD at present. An accumulation of additional cases and further studies of multimodal treatment are required in the future to improve the prognosis.

17 May 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
TGTakanori Goi
Takanori Goi
TNToshiyuki Nakazawa
Toshiyuki Nakazawa
YHYasuo Hirono
Yasuo Hirono
AYAkio Yamaguchi
Akio Yamaguchi